SCHEMBL3661171

SCHEMBL3661171

CC(C)(C)c1cc(C(=O)Nc2ccccc2O)cc(C(C)(C)C)c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.57
TOP2A P11388 1/20 0.57
TOP2B Q02880 1/20 0.57
NPC1 O15118 5/20 0.53
RAB9A P51151 3/20 0.53
TP53 P04637 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
GAA P10253 3/20 0.50
LMNA P02545 2/20 0.50
HTT P42858 2/20 0.50
SYK P43405 1/20 0.50
TERT O14746 1/20 0.47
POLB P06746 1/20 0.47
TNFRSF1A P19438 1/20 0.47
KCNMA1 Q12791 1/20 0.47
ALOX5 P09917 1/20 0.47
PTGS1 P23219 1/20 0.47
PTGS2 P35354 1/20 0.47
CA1 P00915 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11802443 0.87 HPGD (0.59) TOP1TOP2ATOP2BNPC1RAB9A
SCHEMBL8777865 0.85 HDAC1 (0.58) TOP1TOP2ATOP2BPTGS1
SCHEMBL8844428 0.85 NPC1 (0.65) TOP1TOP2ATOP2BNPC1RAB9A
SCHEMBL9417251 0.84 MEN1 (0.60) NPC1RAB9AMEN1KMT2AGAA
SCHEMBL9831396 0.81 HDAC1 (0.48) TOP1TOP2ATOP2BMEN1KMT2A
SCHEMBL8777972 0.80 TOP1 (0.48) TOP1TOP2ATOP2BNPC1RAB9A
SCHEMBL11587346 0.80 TOP1 (0.62) TOP1TOP2ATOP2BNPC1RAB9A
SCHEMBL5225162 0.80 NPC1 (0.69) NPC1RAB9ATP53MEN1KMT2A
SCHEMBL9979204 0.79 TOP1 (0.51) TOP1TOP2ATOP2BNPC1RAB9A
SCHEMBL7733874 0.78 HDAC3 (0.49) NPC1RAB9AMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed
US-3992434-A Ethanol- and substituted ethanolamides of hindered 3,5-dialkyl-4-hydroxybenzoic acids AMERICAN CYANAMID COMPANY (US) 1976-11-16 US disclosed
US-3972927-A Alkylamides of hindered 3,5-dialkyl-4-hydroxybenzoic acids and use as light stabilizers in polyolefins AMERICAN CYANAMID COMPANY (US) 1976-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC TOP1 1052/4885TOP2A 598/4885TOP2B 1039/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR TOP1 611/4885TOP2A 469/4885TOP2B 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.